Transporter Studies in Drug Development: Experience to Date and Follow‐Up on Decision Trees From the International Transporter Consortium

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|94|1|113-125

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.94, Iss.1, 2013-07, pp. : 113-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 52-63

John Wiley & Sons Inc

Access to resources Recommend Favorite

International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 23-26

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 95-112

John Wiley & Sons Inc

Access to resources Recommend Favorite

NPC1L1: from drug target to physiological sterol transporter

By L Pollex Rebecca   A Hegele Robert  

Future Lipidology, Vol. 1, Iss. 3, 2006-06 ,pp. : 247-249

Future Medicine

Access to resources Recommend Favorite

Computational Prospecting for Drug–Transporter Interactions

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 30-32

John Wiley & Sons Inc

Access to resources Recommend Favorite